ARTICLE | Clinical News
Caduet amlodipine besylate/atorvastatin calcium regulatory update
February 9, 2004 8:00 AM UTC
FDA granted marketing approval for Caduet to treat hypertension and hypercholesterolemia. Caduet combines hypertension drug Norvasc amlodipine besylate and cholesterol drug Lipitor atorvastatin, and will be available in multiple dosing combinations. ...